{"transactions":[{"id":1473568,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2024-06-20T20:25:24.000Z","date":"2024-06-18","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary"}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001415889-24-017636","document":"form4-06202024_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924017636/form4-06202024_080620.xml","form_type":"4"}},{"id":1473567,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-20T20:25:24.000Z","date":"2024-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":0.47,"value":1043.87,"ownership":{"direct":true},"balance_after":39255,"source":{"system":"sec-edgar","filing":"0001415889-24-017636","document":"form4-06202024_080620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924017636/form4-06202024_080620.xml","form_type":"4"}},{"id":1473566,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-20T20:25:24.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":41476,"source":{"system":"sec-edgar","filing":"0001415889-24-017636","document":"form4-06202024_080620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924017636/form4-06202024_080620.xml","form_type":"4"}},{"id":1575090,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2024-03-15T21:40:15.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":false,"shares":8666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":17334,"derivative":{"underlying":"Common Stock","underlying_shares":8666},"source":{"system":"sec-edgar","filing":"0001415889-24-008142","document":"form4-03152024_090303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924008142/form4-03152024_090303.xml","form_type":"4"}},{"id":1575089,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2024-03-15T21:40:15.000Z","date":"2024-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2591,"price":0.9,"value":2331.9,"ownership":{"direct":true},"balance_after":35976,"source":{"system":"sec-edgar","filing":"0001415889-24-008142","document":"form4-03152024_090303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924008142/form4-03152024_090303.xml","form_type":"4"}},{"id":1575088,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2024-03-15T21:40:15.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":true,"shares":8666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":38567,"source":{"system":"sec-edgar","filing":"0001415889-24-008142","document":"form4-03152024_090303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924008142/form4-03152024_090303.xml","form_type":"4"}},{"id":1651935,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2024-02-09T22:38:14.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":false,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":6900,"derivative":{"underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001415889-24-003205","document":"form4-02092024_100205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924003205/form4-02092024_100205.xml","form_type":"4"}},{"id":1651934,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2024-02-09T22:38:14.000Z","date":"2024-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2443,"price":0.67,"value":1636.81,"ownership":{"direct":true},"balance_after":29901,"source":{"system":"sec-edgar","filing":"0001415889-24-003205","document":"form4-02092024_100205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924003205/form4-02092024_100205.xml","form_type":"4"}},{"id":1651933,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2024-02-09T22:38:14.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":true,"shares":6900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":32344,"source":{"system":"sec-edgar","filing":"0001415889-24-003205","document":"form4-02092024_100205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588924003205/form4-02092024_100205.xml","form_type":"4"}},{"id":1815203,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2023-08-04T20:45:32.000Z","date":"2023-08-02","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":4750,"derivative":{"underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001415889-23-011867","document":"form4-08042023_080826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923011867/form4-08042023_080826.xml","form_type":"4"}},{"id":1815202,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2023-08-04T20:45:32.000Z","date":"2023-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1422,"price":1.02,"value":1450.44,"ownership":{"direct":true},"balance_after":25444,"source":{"system":"sec-edgar","filing":"0001415889-23-011867","document":"form4-08042023_080826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923011867/form4-08042023_080826.xml","form_type":"4"}},{"id":1815201,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2023-08-04T20:45:32.000Z","date":"2023-08-02","kind":"exercise","planned":false,"acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":26866,"source":{"system":"sec-edgar","filing":"0001415889-23-011867","document":"form4-08042023_080826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923011867/form4-08042023_080826.xml","form_type":"4"}},{"id":1857545,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:54:25.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001415889-23-009750","document":"form4-06132023_080619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923009750/form4-06132023_080619.xml","form_type":"4"}},{"id":1857544,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2023-06-13T20:54:25.000Z","date":"2023-06-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1575,"price":1.137,"value":1790.775,"ownership":{"direct":true},"balance_after":22116,"source":{"system":"sec-edgar","filing":"0001415889-23-009750","document":"form4-06132023_080619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923009750/form4-06132023_080619.xml","form_type":"4"}},{"id":1857543,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2023-06-13T20:54:25.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":23691,"source":{"system":"sec-edgar","filing":"0001415889-23-009750","document":"form4-06132023_080619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923009750/form4-06132023_080619.xml","form_type":"4"}},{"id":1954777,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T23:19:35.000Z","date":"2023-03-13","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary"}],"balance_after":26000,"derivative":{"underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-23-004902","document":"form4-03142023_110331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923004902/form4-03142023_110331.xml","form_type":"4"}},{"id":1954776,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Stock Option (right to purchase)","published_at":"2023-03-14T23:19:35.000Z","date":"2023-03-13","kind":"grant","acquired":true,"shares":79000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":79000,"derivative":{"exercise_price":0.73,"expiration_date":"2033-03-13","underlying":"Common Stock","underlying_shares":79000},"source":{"system":"sec-edgar","filing":"0001415889-23-004902","document":"form4-03142023_110331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923004902/form4-03142023_110331.xml","form_type":"4"}},{"id":2026806,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2023-02-08T22:56:03.000Z","date":"2023-02-07","kind":"exercise","acquired":false,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":13800,"derivative":{"underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001415889-23-002167","document":"form4-02082023_100254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923002167/form4-02082023_100254.xml","form_type":"4"}},{"id":2026805,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2023-02-08T22:56:03.000Z","date":"2023-02-07","kind":"tax_withholding","acquired":false,"shares":1785,"price":1.36,"value":2427.6,"ownership":{"direct":true},"balance_after":18191,"source":{"system":"sec-edgar","filing":"0001415889-23-002167","document":"form4-02082023_100254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923002167/form4-02082023_100254.xml","form_type":"4"}},{"id":2026804,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2023-02-08T22:56:03.000Z","date":"2023-02-07","kind":"exercise","acquired":true,"shares":6900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":19976,"source":{"system":"sec-edgar","filing":"0001415889-23-002167","document":"form4-02082023_100254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923002167/form4-02082023_100254.xml","form_type":"4"}},{"id":2194717,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Restricted Stock Units","published_at":"2022-08-04T20:38:24.000Z","date":"2022-08-02","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":9500,"derivative":{"underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001415889-22-008261","document":"form4-08042022_010847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008261/form4-08042022_010847.xml","form_type":"4"}},{"id":2194716,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2022-08-04T20:38:24.000Z","date":"2022-08-03","kind":"tax_withholding","acquired":false,"shares":1355,"price":1.32,"value":1788.6,"ownership":{"direct":true},"balance_after":13076,"source":{"system":"sec-edgar","filing":"0001415889-22-008261","document":"form4-08042022_010847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008261/form4-08042022_010847.xml","form_type":"4"}},{"id":2194715,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND COO"}}],"security":"Common Stock","published_at":"2022-08-04T20:38:24.000Z","date":"2022-08-02","kind":"exercise","acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14431,"source":{"system":"sec-edgar","filing":"0001415889-22-008261","document":"form4-08042022_010847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008261/form4-08042022_010847.xml","form_type":"4"}},{"id":2234504,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Restricted Stock Units","published_at":"2022-06-13T20:03:47.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":16500,"derivative":{"underlying":"Common stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001179110-22-003288","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022003288/edgar.xml","form_type":"4"}},{"id":2234503,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Stock Option (right to purchase)","published_at":"2022-06-13T20:03:47.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":50250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":50250,"derivative":{"exercise_price":1.33,"expiration_date":"2032-06-10","underlying":"Common stock","underlying_shares":50250},"source":{"system":"sec-edgar","filing":"0001179110-22-003288","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022003288/edgar.xml","form_type":"4"}},{"id":2406719,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-09T21:33:53.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":20700,"derivative":{"underlying":"Common stock","underlying_shares":20700},"source":{"system":"sec-edgar","filing":"0001179110-22-000961","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000961/edgar.xml","form_type":"4"}},{"id":2406718,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2022-02-09T21:33:53.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":62100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":62100,"derivative":{"exercise_price":1.82,"expiration_date":"2032-02-07","underlying":"Common stock","underlying_shares":62100},"source":{"system":"sec-edgar","filing":"0001179110-22-000961","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000961/edgar.xml","form_type":"4"}},{"id":2615473,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-05T00:01:08.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":14250,"derivative":{"underlying":"Common stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001179110-21-007923","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007923/edgar.xml","form_type":"4"}},{"id":2615472,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2021-08-05T00:01:08.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":42750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":42750,"derivative":{"exercise_price":5.19,"expiration_date":"2031-08-02","underlying":"Common stock","underlying_shares":42750},"source":{"system":"sec-edgar","filing":"0001179110-21-007923","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007923/edgar.xml","form_type":"4"}},{"id":2846690,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Appreciation Right","published_at":"2021-02-19T22:26:31.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":301000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement."}],"balance_after":301000,"derivative":{"exercise_price":1.51,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":301000},"source":{"system":"sec-edgar","filing":"0001179110-21-002007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021002007/edgar.xml","form_type":"4"}},{"id":2855472,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-17T13:55:28.000Z","date":"2021-02-16","kind":"purchase","acquired":true,"shares":15000,"price":1,"value":15000.0,"ownership":{"direct":true},"balance_after":145213,"source":{"system":"sec-edgar","filing":"0001179110-21-001784","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021001784/edgar.xml","form_type":"4"}},{"id":2964494,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-30T22:11:54.000Z","date":"2020-11-27","kind":"purchase","acquired":true,"shares":4614,"price":0.26,"value":1199.64,"ownership":{"direct":true},"balance_after":130213,"source":{"system":"sec-edgar","filing":"0001179110-20-011470","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020011470/edgar.xml","form_type":"4"}},{"id":2964493,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-30T22:11:54.000Z","date":"2020-11-25","kind":"purchase","acquired":true,"shares":16755,"price":0.26,"value":4356.3,"ownership":{"direct":true},"balance_after":125599,"source":{"system":"sec-edgar","filing":"0001179110-20-011470","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020011470/edgar.xml","form_type":"4"}},{"id":3085076,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Appreciation Right","published_at":"2020-07-10T21:48:30.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":543000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":543000,"derivative":{"exercise_price":0.56,"expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":543000},"source":{"system":"sec-edgar","filing":"0001179110-20-008212","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020008212/edgar.xml","form_type":"4"}},{"id":3141109,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T13:09:16.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":21000,"price":0.36,"value":7560.0,"ownership":{"direct":true},"balance_after":108844,"source":{"system":"sec-edgar","filing":"0001179110-20-006358","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020006358/edgar.xml","form_type":"4"}},{"id":3331474,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2019-12-26T14:06:46.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":65000,"derivative":{"exercise_price":0.31,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001179110-19-013138","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019013138/edgar.xml","form_type":"4"}},{"id":3358968,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to purchase)","published_at":"2019-11-26T12:50:04.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":87500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20."}],"balance_after":87500,"derivative":{"exercise_price":0.2,"exercise_date":"2019-11-25","expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001179110-19-012056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019012056/edgar.xml","form_type":"4"}},{"id":3358967,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-26T12:50:04.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":87500,"price":0.2,"value":17500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20."}],"balance_after":87844,"source":{"system":"sec-edgar","filing":"0001179110-19-012056","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019012056/edgar.xml","form_type":"4"}},{"id":3859171,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2018-07-30T21:26:33.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":384950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":384950,"derivative":{"exercise_price":0.46,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":384950},"source":{"system":"sec-edgar","filing":"0001179110-18-010010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018010010/edgar.xml","form_type":"4"}},{"id":4105720,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2018-01-05T21:49:52.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":31024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years in 36 equal monthly installments."}],"balance_after":31024,"derivative":{"exercise_price":1.5,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":31024},"source":{"system":"sec-edgar","filing":"0001179110-18-000601","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018000601/edgar.xml","form_type":"4"}},{"id":4342261,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-28T19:11:44.000Z","date":"2017-04-26","kind":"purchase","acquired":true,"shares":1429,"price":2.1,"value":3000.9,"ownership":{"direct":true},"balance_after":5155,"source":{"system":"sec-edgar","filing":"0001179110-17-006249","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911017006249/edgar.xml","form_type":"4"}},{"id":4486757,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2017-01-19T18:35:23.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":19413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years in 36 equal monthly installments."}],"balance_after":19413,"derivative":{"exercise_price":2.7,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":19413},"source":{"system":"sec-edgar","filing":"0001179110-17-001044","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911017001044/edgar.xml","form_type":"4"}},{"id":4517233,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":83447,"kind":"person","name":"Guerin Mark Patrick","position":1,"cik":"0001607714","reported_name":"Guerin Mark Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2016-12-19T21:41:23.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":5587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years in 36 equal monthly installments."}],"balance_after":5587,"derivative":{"exercise_price":2.65,"expiration_date":"2026-12-15","underlying":"Common Stock","underlying_shares":5587},"source":{"system":"sec-edgar","filing":"0001179110-16-033200","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911016033200/edgar.xml","form_type":"4"}}]}